MARCUS DECARVALHO: Open Payments
NPI 1427213727 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$919 in 47 payments from 10 companies in 2025. Trend: 2023 $1,444 · 2024 $737 · 2025 $919
Food & beverage: $919
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $157 |
| Alkermes, Inc. | 9 | $147 |
| Janssen Pharmaceuticals, Inc | 5 | $126 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $123 |
| Lundbeck LLC | 5 | $103 |
| E.R. Squibb & Sons, L.L.C. | 3 | $81 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Neos Therapeutics, LP | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: FANAPT, ARISTADA, TRINTELLIX, REXULTI, COBENFY, SPRAVATO, Auvelity, UZEDY.
Industry payments across FL — which companies pay providers there.
